Emerging issues related to COVID-19 vaccination in patients with cancer

Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The r...

Descripción completa

Detalles Bibliográficos
Autores principales: Saini, Kamal S., Martins-Branco, Diogo, Tagliamento, Marco, Vidal, Laura, Singh, Navneet, Punie, Kevin, Saini, Monika Lamba, Chico, Isagani, Curigliano, Giuseppe, de Azambuja, Evandro, Lambertini, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208766/
https://www.ncbi.nlm.nih.gov/pubmed/34137014
http://dx.doi.org/10.1007/s40487-021-00157-1
_version_ 1783708986741096448
author Saini, Kamal S.
Martins-Branco, Diogo
Tagliamento, Marco
Vidal, Laura
Singh, Navneet
Punie, Kevin
Saini, Monika Lamba
Chico, Isagani
Curigliano, Giuseppe
de Azambuja, Evandro
Lambertini, Matteo
author_facet Saini, Kamal S.
Martins-Branco, Diogo
Tagliamento, Marco
Vidal, Laura
Singh, Navneet
Punie, Kevin
Saini, Monika Lamba
Chico, Isagani
Curigliano, Giuseppe
de Azambuja, Evandro
Lambertini, Matteo
author_sort Saini, Kamal S.
collection PubMed
description Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.
format Online
Article
Text
id pubmed-8208766
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-82087662021-06-17 Emerging issues related to COVID-19 vaccination in patients with cancer Saini, Kamal S. Martins-Branco, Diogo Tagliamento, Marco Vidal, Laura Singh, Navneet Punie, Kevin Saini, Monika Lamba Chico, Isagani Curigliano, Giuseppe de Azambuja, Evandro Lambertini, Matteo Oncol Ther Editorial Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer. Springer Healthcare 2021-06-16 /pmc/articles/PMC8208766/ /pubmed/34137014 http://dx.doi.org/10.1007/s40487-021-00157-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Editorial
Saini, Kamal S.
Martins-Branco, Diogo
Tagliamento, Marco
Vidal, Laura
Singh, Navneet
Punie, Kevin
Saini, Monika Lamba
Chico, Isagani
Curigliano, Giuseppe
de Azambuja, Evandro
Lambertini, Matteo
Emerging issues related to COVID-19 vaccination in patients with cancer
title Emerging issues related to COVID-19 vaccination in patients with cancer
title_full Emerging issues related to COVID-19 vaccination in patients with cancer
title_fullStr Emerging issues related to COVID-19 vaccination in patients with cancer
title_full_unstemmed Emerging issues related to COVID-19 vaccination in patients with cancer
title_short Emerging issues related to COVID-19 vaccination in patients with cancer
title_sort emerging issues related to covid-19 vaccination in patients with cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208766/
https://www.ncbi.nlm.nih.gov/pubmed/34137014
http://dx.doi.org/10.1007/s40487-021-00157-1
work_keys_str_mv AT sainikamals emergingissuesrelatedtocovid19vaccinationinpatientswithcancer
AT martinsbrancodiogo emergingissuesrelatedtocovid19vaccinationinpatientswithcancer
AT tagliamentomarco emergingissuesrelatedtocovid19vaccinationinpatientswithcancer
AT vidallaura emergingissuesrelatedtocovid19vaccinationinpatientswithcancer
AT singhnavneet emergingissuesrelatedtocovid19vaccinationinpatientswithcancer
AT puniekevin emergingissuesrelatedtocovid19vaccinationinpatientswithcancer
AT sainimonikalamba emergingissuesrelatedtocovid19vaccinationinpatientswithcancer
AT chicoisagani emergingissuesrelatedtocovid19vaccinationinpatientswithcancer
AT curiglianogiuseppe emergingissuesrelatedtocovid19vaccinationinpatientswithcancer
AT deazambujaevandro emergingissuesrelatedtocovid19vaccinationinpatientswithcancer
AT lambertinimatteo emergingissuesrelatedtocovid19vaccinationinpatientswithcancer

Ejemplares similares